Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations
ClinicalTrials.gov study NCT06940401. IPD Sharing: NO. Countries: 1. Publications: 0.
Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04285671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EGFR Mutations on ctDNA in Patients With Advanced NSCLC
ClinicalTrials.gov study NCT02623257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)
ClinicalTrials.gov study NCT02475720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC
ClinicalTrials.gov study NCT04405674. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy
ClinicalTrials.gov study NCT05314296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00830245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detecting EGFR T790M Mutations From Circulating Tumor Cells
ClinicalTrials.gov study NCT01734915. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NEoadjuvant Gefitinib fOllowed by Surgery and gefiTinib In unresectAble sTage III NSCLC With EGFR Mutations.
ClinicalTrials.gov study NCT02347839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
ClinicalTrials.gov study NCT05258279. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05267288. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
ClinicalTrials.gov study NCT04591002. IPD Sharing: NO. Countries: 1. Publications: 0.
Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases
ClinicalTrials.gov study NCT07304739. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients
ClinicalTrials.gov study NCT02914990. IPD Sharing: NO. Countries: 1. Publications: 0.
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
ClinicalTrials.gov study NCT03265496. IPD Sharing: NO. Countries: 1. Publications: 0.
A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
ClinicalTrials.gov study NCT02847377. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy
ClinicalTrials.gov study NCT02906163. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients
ClinicalTrials.gov study NCT05463224. IPD Sharing: NO. Countries: 1. Publications: 0.
Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer
ClinicalTrials.gov study NCT05517083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT02001896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.